Integra LifeSciences Holdings (IART)
Return on assets (ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -6,944 | 67,741 | 180,550 | 169,075 | 133,892 |
| Total assets | US$ in thousands | 4,037,420 | 3,781,990 | 3,889,760 | 3,782,380 | 3,615,140 |
| ROA | -0.17% | 1.79% | 4.64% | 4.47% | 3.70% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $-6,944K ÷ $4,037,420K
= -0.17%
Integra LifeSciences Holdings' return on assets (ROA) has shown some fluctuations over the years. The ROA increased from 3.70% in December 2020 to 4.47% in December 2021, indicating improved efficiency in generating profit from its assets. Subsequently, the ROA further increased to 4.64% by December 2022, reflecting continued positive performance.
However, there was a notable decrease in ROA to 1.79% by December 2023, possibly suggesting challenges in asset utilization or profitability during that period. Moreover, the ROA turned negative at -0.17% by December 2024, indicating that the company's assets were not generating sufficient profits to cover the costs associated with them.
Overall, the fluctuation in Integra LifeSciences Holdings' ROA over these years suggests varying levels of effectiveness in utilizing its assets to generate profit. It would be essential to investigate the reasons behind these changes to understand the company's financial performance and make informed decisions.
Peer comparison
Dec 31, 2024